healthcare

J&J vaccine benefit outweighs “very rare” blood clot risk says EU regulator

J&J vaccine benefit outweighs “very rare” blood clot risk says EU regulator

The Johnson & Johnson single-shot COVID-19 vaccine can in very rare cases lead to unusual blood clots, the European Medicines Agency has concluded, though experts maintain the benefits outweigh the risks. It's the second coronavirus vaccine to be subject to extra warning labeling by the EU regulator, after AstraZeneca's drug was also linked to blood clotting issues.

Continue Reading

We need a COVID-19 blood clot and vaccine breakthrough reality check

We need a COVID-19 blood clot and vaccine breakthrough reality check

People vaccinated against COVID-19 can still catch coronavirus and some immunizations carry an increased risk of blood clots, new research confirms, but officials maintain that the benefits still significantly outweigh the risks. The ongoing studies - running in parallel to COVID-19 vaccinations, as healthcare providers attempt to slow the global pandemic - underscore the need for comparative nuance when it comes to deciding about whether to get a vaccine shot.

Continue Reading

It’s looking even more likely we’ll need yearly COVID-19 shots

It’s looking even more likely we’ll need yearly COVID-19 shots

Annual COVID-19 vaccinations are probably going to be necessary to keep coronavirus at bay, Pfizer's CEO has suggested, and indeed even that may not be enough as the population gets to grips with the extent of the disease and its variants. The warning further dashes hopes that getting immunized this year will be a long-term preventative for serious cases of the potentially deadly illness.

Continue Reading

Controversial stem cell research makes human-monkey hybrids

Controversial stem cell research makes human-monkey hybrids

A groundbreaking experiment blending human and monkey cells could pave the way to artificially-grown replacement organs - while raising new ethical questions about so-called chimeric hybrids. It's the latest expansion of stem cell research, which has simultaneously fascinated scientists hoping to unlock new disease treatments and more, while horrifying groups concerned about the ethics or misuse of the technology.

Continue Reading

Apple Fitness+ adds workouts for beginners plus older and pregnant users

Apple Fitness+ adds workouts for beginners plus older and pregnant users

Apple Fitness+ is gaining new workouts today, adding specific sessions for pregnancy and that target older adults and beginners. It's part of a workout boost for the Apple Watch-centered subscription fitness system, and will also include a new Time to Walk session with Jane Fonda.

Continue Reading

US halts J&J one-shot COVID-19 vaccinations over “extremely rare” clot risk

US halts J&J one-shot COVID-19 vaccinations over “extremely rare” clot risk

US immunizations with the Johnson & Johnson COVID-19 vaccine have been put on hold, as the CDC and FDA assesses six reported cases of rare blood clotting in America. The J&J Jannsen vaccine has been administered more than 6.8 million times in the US so far, since the one-shot drug received authorization under the FDA's pandemic EUA program.

Continue Reading

Pfizer-BioNTech ask FDA to expand COVID-19 vaccine to 12-15 year olds

Pfizer-BioNTech ask FDA to expand COVID-19 vaccine to 12-15 year olds

Pfizer and BioNTech are requesting FDA authorization to expand their COVID-19 vaccine to children as young as 12, claiming recently-released trial results demonstrate the immunizations' safety. Currently, the Pfizer-BioNTech vaccine, BNT162b2, is being administered in the US under an FDA emergency use authorization (EUA) for people aged 16 or above.

Continue Reading

J&J’s one-shot COVID-19 vaccine is under blood clot investigation

J&J’s one-shot COVID-19 vaccine is under blood clot investigation

Johnson & Johnson's single-shot COVID-19 vaccine is being investigated by the European Medicines Agency over blood clot concerns, the second coronavirus vaccine to fall under the microscope for potentially fatal side-effects. The EMA's safety committee, PRAC, recommended continued use of the University fo Oxford and AstraZeneca's vaccine earlier this week, though required possible blood issues be added to the list of rare risks.

Continue Reading

COVID-19 biosensors could make your phone a virus-spotter

COVID-19 biosensors could make your phone a virus-spotter

GE is working on tiny sensors that could spot the COVID-19 virus, small enough to integrate into smartphones, wearables, and other surfaces as a digital watchdog for potential routes of infection. The electronic nano-sensors distill down what would traditionally demand large and complex lab equipment into something far smaller, focused on detecting a specific thing such as coronavirus.

Continue Reading

EU regulator finds “very rare” AstraZeneca vaccine blood clot risk: The symptoms to watch for

EU regulator finds “very rare” AstraZeneca vaccine blood clot risk: The symptoms to watch for

The AstraZeneca COVID-19 vaccine could lead to blood clots in a small subset of people, the European drug regulator has concluded, though it's a "very rare" possibility and shouldn't prevent immunizations in general. The European Medicines Agency (EMA) had been assessing the safety of Vaxzevria - developed by the University of Oxford in the UK and AstraZeneca - after reports of an uptick in dangerous blood clots among some people who had been given the drug.

Continue Reading

Historic windpipe transplant could be huge news for COVID-19 patients

Historic windpipe transplant could be huge news for COVID-19 patients

The first human tracheal transplant has been successfully completed, potentially paving the way to addressing medical conditions that contribute to thousands of deaths each year. The surgery, carried out by surgeons at Mount Sinai Hospital in New York City, took 18 hours to put a new windpipe into a patient who, until now, had been breathing through a tracheostomy.

Continue Reading

Google’s COVID-19 vaccine ad didn’t make me cry – but it did make me hopeful

Google’s COVID-19 vaccine ad didn’t make me cry – but it did make me hopeful

Tear-jerker adverts can be tricky when it comes to encouraging changes of behavior, but it seems like Google has struck a nerve with its latest about the COVID-19 vaccine and a potential return to normalcy. Aired for the first time during the NCAA Final Four game this weekend, the minute-long commercial is a reminder of what the "new normal" has been over the past twelve months or so.

Continue Reading

1 2 3 4 Next